ArticleBMC public health2026
Examining public perceptions of cardiovascular disease risk screening programs in community pharmacies: a mixed-methods study.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiovascular diseases (CVDs) are the leading cause of mortality and morbidity in Saudi Arabia. Early identification and management of risk are critical to addressing this burden. Community pharmacies (CPs) offer an accessible setting for proactive screening; however, pharmacy-based CVD initiatives remain underexplored locally despite demonstrated success internationally. Understanding public perspectives is therefore essential to inform service development.
aimTo assess the perceptual factors shaping public acceptance of CP-based CVD risk screening services in Saudi Arabia.
methodA convergent parallel mixed-methods design was employed, combining an online questionnaire and semi-structured interviews. Quantitative data were analysed descriptively, while qualitative data were examined using framework analysis guided by the Health Belief Model (HBM), a framework used to explain how beliefs influence health behaviours.
resultsA total of 523 survey responses and 9 interviews were analysed. Most participants were young, educated Saudi nationals, and reported visiting CPs more frequently than general practitioners. Over half expressed confidence in pharmacists' competence to conduct CVD risk screening, and 60% felt comfortable discussing CVD-related concerns. HBM constructs highlighted perceived susceptibility, severity, and self-efficacy as key motivators, with accessibility and convenience serving as important cues to action. However, concerns related to privacy, cost, and staffing limitations remained significant deterrents.
conclusionPublic perception of CP-based CVD screening were generally positive, with accessibility, trust in pharmacists, and perceived benefits supporting engagement. However, views regarding suitability were mixed, and concerns related to privacy, cost, and staffing remain important barriers. The Health Belief Model (HBM) provided a useful framework for understanding these motivations and barriers. Addressing these issues is essential for successful implementation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.